ELCC 2014: Industry Participation

The European Lung Cancer Conference (ELCC), is the most important conference in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.

It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.

Fast facts: ELCC 2014

  • Over 1400 international participants expected
  • Specialists and key opinion leaders from all over the world in one place and as one community
  • Two key note lectures and 14 educational sessions running over four days
  • An internationally-renowned faculty
  • Seven Industry Satellite Symposia
  • Vibrant commercial exhibition
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution the following organisations have made to the ELCC conferences over the years.

Past attendees
Abbott Laboratories Agennix Astrazeneca
Bayer Schering Pharma Boehringer Ingelheim Cis Bio International
Daiichi Sankyo Europe Eli Lilly Elsevier
GE Healthcare GSK Karl Storz
Merck Serono Microsulis Medical Ltd. MSD
Novartis Oncology Olympus Medical Systems Europe Pfizer Oncology
Qiagen Roche Rosetta Genomics
Sanofi Varian Medical Systems  

How can I participate in ELCC 2014?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our conferences.

Contact the  ESMO Events Sponsorship Team for more details. We look forward to hearing from you!